Relationship Between Potential Antihypertensive Drug Interactions and Target Blood Pressure in Outpatients with Chronic Kidney Disease

Lutfi Hidiyaningtyas; Mardiana Lestari; Trinita Puspitasari

Authors

Lutfi Hidiyaningtyas Universitas Jenderal Achmad Yani Yogyakarta
Mardiana Lestari Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia
Trinita Puspitasari Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia

Keywords:

Drug Interaction, Antihypertensive, Chronic Kidney Disease

Abstract

Background: Chronic kidney disease (CKD) is an increasingly prevalent condition globally and is strongly associated with cardiovascular disease (CVD). Hypertension frequently occurs during the development of kidney disease and is a leading cause of its progression. CKD patients with complications and comorbidities often require combination therapy. However, some drug combinations can cause adverse drug reactions and reduce the efficacy of therapy. One such reaction is failing to achieve the blood pressure target; Method: This research is a non-experimental, analytical study with retrospective sampling. The sample for this study consisted of 71 patients. Potential drug interactions were analyzed using the drug interaction checker application on drug.com. Univariate analysis was performed to describe patient characteristics, and bivariate analysis using the Chi-square statistical test was performed to examine the relationship between the potential interactions of antihypertensive drugs and blood pressure targets; Results: The correlation analysis test results showed no relationship between the potential interaction of antihypertensive drugs and the target blood pressure of CKD patients (p-value = 0.607); Conclusion: There is potential for antihypertensive drug interactions in CKD patients, but they do not statistically affect blood pressure targets.

Author Biographies

Mardiana Lestari, Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia

Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia

Trinita Puspitasari, Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia

Pharmacy Department, Faculty of Health, Jenderal Achmad Yani University, DI Yogyakarta, Indonesia

References

Cheung AK, Chang TI, Cushman WC, Furth SL, Hou FF, Ix JH, et al. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int. 2021; 99(3): S1–87. https://www.kidney-international.org/article/S0085-2538(20)31270-9/fulltext.

Kovesdy CP. Epidemiology of chronic kidney disease: an update 2022. Kidney Int Suppl (2011). 2022; 12(1): 7–11. https://doi.org/10.1016/j.kisu.2021.11.003.

Hustrini NM. Chronic Kidney Disease Care in Indonesia: Challenges and Opportunities. Acta Med Indones. 2023; 55(5): 1–3.

Riskesdas. Laporan Provinsi di Yogyakarta RISKESDAS 2018. 2018. 7823–7830 p.

Indonesian Ministry of Health. Keputusan Menteri Kesehatan Republik Indonesia Tentang Pedoman Nasional Pelayanan Kedokteran Tata Laksana Ginjal Kronik. Indonesian Ministry of Health. 2023; (11): 1–189.

Afifah F, Amal S. Evaluasi Penggunaan Obat Antihipertensi Pada Pasien Rawat Jalan GGK dengan Hemodialisa di RSUP dr. Soeradji Tirtonegoro Klaten Tahun 2017. Pharmasipha. 2019; 3(2): 21–27. https://doi.org/10.21111/pharmasipha.v3i2.3404.

Ameer OZ. Hypertension in chronic kidney disease: What lies behind the scene. Front Pharmacol. 2022; 13: 949260. https://doi.org/10.3389/fphar.2022.949260.

Weldegiorgis M, Woodward M. The impact of hypertension on chronic kidney disease and end-stage renal disease is greater in men than women: a systematic review and meta-analysis. BMC Nephrol. 2020; 21(1): 506. https://doi.org/10.1186/s12882-020-02151-7.

Georgianos PI, Agarwal R. Hypertension in chronic kidney disease - Treatment standard 2023. Nephrol Dial Transplant. 2023; 38(12): 2694–2703. https://doi.org/10.1093/ndt/gfad118.

Karinda TUS, Sugeng CEC, Moeis ESy. Gambaran Komplikasi Penyakit Ginjal Kronik Non Dialisis di Poliklinik Ginjal-Hipertensi RSUP Prof. Dr. R. D. Kandou Periode Januari 2017 – Desember 2018. e-CliniC. 2019; 7(2).

Pramitaningastuti A. Overview of Polypharmacy and Drug Interactions in Chronic Kidney Disease Patients at Siloam Hospitals Lippo Village. Media Farmasi Indonesia. 2024; 19(1). https://doi.org/10.53359/mfi.v19i1.271.

Oosting IJ, Colombijn JMT, Kaasenbrood L, Liabeuf S, Laville SM, Hooft L, et al. Polypharmacy in Patients with CKD: A Systematic Review and Meta-Analysis. Kidney360 [Internet]. 2024; 5(6): 841–850. https://doi.org/10.34067/kid.0000000000000447.

Probosiwi N, Laili NF, Ilmi T, Sisiwidiasari A. Analisis Interaksi Obat Yang Potensial Pada Pasien Gagal Ginjal Kronis Dengan Penyakit Penyerta Di Rs. X Kota Kediri: Analysis Of Potential Drug Interaction In Chronic Kidney Failure Patients With Comorbidities at X Hospital Kediri City. Jurnal Inovasi Farmasi Indonesia (JAFI). 2023; 5(1): 60–72. https://doi.org/10.30737/jafi.v5i1.5181.

Kshirsagar PV, Nemane PS, Khose AS, Nalwade OB. A review on drug interaction. World Journal of Biology Pharmacy and Health Sciences. 2024; 18(3): 031–042. https://doi.org/10.30574/wjbphs.2024.18.3.0284.

Gabay M, Spencer SH. Drug Interactions: Scientific and Clinical Principles. PSAP 2021 Book 3 • Chronic Conditions and Public Health; 7–28. https://www.accp.com/docs/bookstore/psap/p2021b3_sample.pdf.

Onor IO, Ahmed F, Nguyen AN, Ezebuenyi MC, Obi CU, Schafer AK, et al. Polypharmacy in chronic kidney disease: Health outcomes & pharmacy-based strategies to mitigate inappropriate polypharmacy. Am J Med Sci [Internet]. 2024; 367(1): 4–13. https://doi.org/10.1016/j.amjms.2023.10.003.

Hardianti H, Herliany YS. Potensi Interaksi Obat Antihipertensi Pada Pasien Penyakit Ginjal Kronik di Rumah Sakit Khusus Ginjal Bandung. Pharmaceutical Science and Clinical Pharmacy. 2023; 1(1): 24–28. http://dx.doi.org/10.61329/pscp.v1i1.7.

Makmur SA, Madania M, Rasdianah N. Gambaran Interaksi Obat pada Pasien Gagal Ginjal Kronik dalam Proses Hemodialisis. Indonesian Journal of Pharmaceutical Education. 2022; 2(3): 218–229. https://doi.org/10.37311/ijpe.v2i2.13333.

Ghelichi-Ghojogh M, Fararouei M, Seif M, Pakfetrat M. Chronic Kidney Disease and its Health-Related Factors: a Case-Control Study. BMC Nephrol. 2022; 23(1): 1–7. https://doi.org/10.1186/s12882-021-02655-w.

Utami IAA, Santhi DGDD, Lestari AAW. Prevalensi dan Komplikasi pada Penderita Gagal Ginjal Kronik yang Menjalani Hemodialisa di Rumah Sakit Umum Pusat Sanglah Denpasar Tahun 2018. Intisari Sains Medis. 2020; 11(3): 1216–1221. https://doi.org/10.15562/ism.v11i3.691.

Prihatiningtias KJ, Arifianto. Faktor-Faktor Risiko Terjadinya Penyakit Ginjal Kronik. Jurnal Ners Widya Husada. 2017; 4(2): 57–64. https://doi.org/10.33666/jners.v4i2.314.

Al Kamaliah NI, Cahaya N, Rahmah S. Gambaran Karakteristik Pasien Gagal Ginjal Kronik yang Menggunakan Suplemen Kalsium di Poliklinik Sub Spesialis Ginjal Hipertensi Rawat Jalan RSUD Ulin Banjarmasin. Jurnal Pharmascience, 2021; 08(01): 111–124. https://dx.doi.org/10.20527/jps.v8i1.8599.

Kartikawati ND, Andayani TM, Endarti D. Gambaran dan Luaran Klinik Terapi Anemia pada Pasien Chronic Kidney Disease dengan Hemodialisis di RS PKU Muhammadiyah Yogyakarta. Majalah Farmaseutik. 2023; 19(1): 148–154. https://doi.org/10.22146/farmaseutik.v19i1.74877.

DiPiro JT, Yee GC, Haines ST, Nolin TD, Ellingrod VL, Posey LM. DiPiro’s Pharmacotherapy a Pathophysiologic Approach. 2023. 53–54 p.

Sinaga CR, Widodo G pamudji, Andayani TM. EQ-5D-5L untuk Pengukuran Biaya dan Indeks Utilitas pada Pasien Gagal Ginjal Kronik dengan Hemodialisis. Jurnal Penelitian Kesehatan Suara Forikes [Internet]. 2023; 14(2): 286–290. http://dx.doi.org/10.33846/sf14210.

Maryatun S, Padmasari S. Analisis Hubungan Polifarmasi dengan Potensi Interaksi Obat pada Pasien Hipertensi Rawat Jalan di RSUD Sleman Yogyakarta. Thesis. Universitas Jenderal Achmad Yani Yogyakarta. 2022.

Rengga MPE, Kono RB, Beama CA. Analisis Interaksi Obat Penyakit Ginjal Kronik di RSUD Prof. Dr. W. Z. Johannes Kupang. MPI (Media Pharmaceutica Indonesiana). 2021; 3(3): 179–187. https://doi.org/10.24123/mpi.v3i3.3937.

Febriyani G. Analisis Hubungan Polifarmasi dan Interaksi Obat Antihipertensi pada Pasien Gagal Ginjal Kronik dengan Hemodialisis di RSUD Sleman Yogyakarta. Jurnal Farmasi Indonesia. 2024; 16(2): 177–186. https://doi.org/10.35617/jfionline16i2.231.

Hanutami B, Dandan KL. Identifikasi Potensi Interaksi Antar Obat pada Resep Umum di Apotek Kimia Farma 58 Kota Bandung bulan April 2019. Farmaka. 2019; 17(2): 57–64. https://doi.org/10.24198/jf.v17i2.22956.g11612.

Frakastiwi G. Kajian Interaksi Obat Pasien Hipertensi yang disertai Gagal Ginjal Kronik di Instalasi Rawat Inap Rumah Sakit Umum Pusat (RSUP) Fatmawati Jakarta. Thesis. UIN Syarif Hidayatullah. 2020. 1–239.

Setyoningsih H, Zaini F. Hubungan Interaksi Obat Terhadap Efektivitas Obat Antihipertensi di RSUD dr. R. Soetrasno Rembang. Cendekia Journal of Pharmacy. 2022; 6(1): 76–88. https://doi.org/10.31596/cjp.v6i1.186.